Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.

Naidoo A, Chirehwa M, McIlleron H, Naidoo K, Essack S, Yende-Zuma N, Kimba-Phongi E, Adamson J, Govender K, Padayatchi N, Denti P.
Journal of Antimicrobial Chemotherapy 2017 February. doi: 10.1093/jac/dkx004.

Read publication
Trump's “global gag rule”: implications for human rights and global health.

Singh JA, Abdool Karim SS.
The Lancet Global Health 2017; 5(4): e387-e389.

Read publication
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in Sub-Saharan Africa: a retrospective multi-centre cohort study.

Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ , Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK.
Lancet Infectious Diseases 2017; 17(3):296-304.

Read publication
Placental leptin mRNA expression and serum leptin levels in pre-eclampsia associated with HIV infection.

Haffejee F, Naicker T, Singh M, Kharsany AB, Adhikari M, Singh R, Maharaj N, Moodley J.
Journal of Obstetrics and Gynaecology 2017; 37(1):48-52.

Read publication
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.

Moore PL, Gorman J, Doria-Rose NA, Morris L.
Immunological Reviews 2017; 275(1):217-229.

Read publication
Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Ramsuran V, Hernandez-Sanchez PG, O'HUigin C, Sharma G, Spence N, Augusto DG, Gao X, Garcia-Sepulveda CA, Kaur G, Mehra NK, Carrington M.
Journal of Immunology 2017; 198(6):2320-2329.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.